System and method for identifying road features

Details for Australian Patent Application No. 2006304589 (hide)

Owner Dash Navigation Inc.

Inventors Weisenfluh, Craig; Smartt, Brian

Agent Spruson & Ferguson

Pub. Number AU-B-2006304589

PCT Pub. Number WO2007/047780

Priority UNKNOWN 16.10.06 US; 60/726,894 14.10.05 US

Filing date 16 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 10 March 2011

International Classifications

G01B 3/22 (2006.01) Instruments as specified in the subgroups and characterised by the use of mechanical measuring means - Feeler-pin gauges, e.g. dial gauges

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/047780 Priority application(s): WO2007/047780

10 March 2011 Application Accepted

  Published as AU-B-2006304589

7 July 2011 Application for Amendment

  The nature of the amendment is: Amend the priority details to read 11/581,808 16 Oct 2006 US and 60/726,894 14 Oct 2005 US. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

3 November 2011 Amendment Made

  The nature of the amendment is: Amend the priority details to read 60/726,894 14 Oct 2005 US and 11/581,808 16 Oct 2006 US 2006320431 E. I. Du Pont De Nemours and Company The nature of the amendment is as shown in the statement(s) filed 10 Jun 2011

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304590-Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings

2006304584-Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders